LB54640 Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Conditions: Obesity Due to Melanocortin 4 Receptor Deficiency; Genetic Obesity; Obesity Intervention: Drug: LB54640 Sponsor: LG Chem Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials